Biocept news 2020 (BIOC) Q4 2020 Results Conference Call March 29, 2021 4:30 PM ETCompany Participants Jody Cain - LHAMichael Nall - CEO, President & Sep 15, 2025 · See the latest Biocept Inc stock price (BIOCQ:PINX), related news, valuation, dividends and more to help you make your investing decisions. 8 million in Q4 2019, marking its first profitable quarter with a net income of $1. Jan 8, 2020 · SAN DIEGO, Jan. Feb 7, 2020 · Certain Warrants of Biocept, Inc. announced that it has received more than 150,000 samples for COVID-19 RT-PCR testing to date and has continued to report the vast majority of results to customers within 48 hours of Aug 6, 2020 · SAN DIEGO, Aug. The announcement Monday comes as the San Diego-based company advances the usage of its flagship Target Selector technology platform. Feb 7, 2020 · Certain Common Stock of Biocept, Inc. , our independent registered public accounting firm, as set forth in their report thereon (which includes an explanatory paragraph related to the change in the SAN DIEGO, May 14, 2020 /PRNewswire/ -- Biocept, Inc. 5 million in financing so far in 2020 Ramping up global marketing efforts for its blood tests and related products to grow organically What Biocept does: Biocept Inc (NASDAQ:BIOC) is a molecular diagnostics company focused on changing the way physicians examine blood in Nov 12, 2020 · Presentation Operator MessageOperator Ladies and gentlemen, thank you for standing by. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information The financial statements of Biocept, Inc. “The vote was to be counted” at Biocept’s annual meeting on June 5, 2020. Sep 8, 2023 · Biocept will provide expertise, including consulting on equipment and materials sourcing, as well as providing the necessary technology and training to perform CNSide. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information Aug 19, 2020 · SAN DIEGO, Aug. Use the PitchBook Platform to explore the full profile. (Nasdaq: BIOC), a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended December 31, 2020 and provides a business update. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that Michael W. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic tests and services for physicians treating cancer patients, announces Nov 14, 2020 · Industry Analysts Just Made An Incredible Upgrade To Their Biocept, Inc. 00% 0. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information Biocept Inc (NASDAQ:BIOC), a molecular diagnostics company, has announced that it is relocating its corporate offices and advanced laboratory to a new location in San Diego, California. The company will host a conference call at 4:30 PM ET to discuss the results and take questions from investors. May 14, 2020 · SAN DIEGO, May 14, 2020 /PRNewswire/ -- Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, announces that it is relocating its corporate offices and CLIA-certified, CAP-accredited high complexity laboratory to a new location in San Diego. SAN DIEGO, May 20, 2020 /PRNewswire/ -- Biocept, Inc. 49 million and Dec 14, 2020 · News from biocept, inc. stock news by MarketWatch. Nov 23, 2022 · In Brief This Week: Burst Diagnostics, Agilent, Abbott, DermTech, Biocept, More News items for the week of Sept. 02 statement, which is an earnings press release pertaining to results of operations and financial condition. announced a development agreement focused on the co-development by Biocept and Aegea of a highly sensitive PCR-based assay designed by Aegea for detecting Jan 20, 2022 · According to city officials, this project is one of 26 major projects in the city’s consent decree under Akron Waterways Renewed! (AWR!) program. , Q2 2020 Earnings Call, Aug 12, 2020 Mar 30, 2021 · Biocept, Inc. (NASDAQ: BIOC) will release its financial results for the second quarter of 2020 on August 12, 2020, after market close. ’s Annual Report on Form 10-K for the year ended December 31, 2019 have been audited by Mayer Hoffman McCann P. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30, 2020 after the market closes on Wednesday, August 12, 2020. Biocept specializes in molecular diagnostic tests for cancer, leveraging its proprietary Target Selector™ liquid biopsy technology to provide actionable insights Aug 25, 2020 · News videos - Biocept, Inc. appearing in Biocept, Inc. On June 5, 2020, the Company held the Annual Meeting. Find market predictions, BIOCQ financials and market news. Eastern time to discuss these results and address questions from the investment community. They anticipate the company to incur a final loss in 2024, before generating positive profits of US$29m in 2025 Find the latest Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information Jun 5, 2020 · On June 10, 2020, Biocept, Inc. 2020 Q2 earnings call transcript for Biocept, Inc. Nov 4, 2020 · SAN DIEGO, Nov. 4 million in May 14, 2020 · The following information was filed by Biocept Inc (BIOC) on Wednesday, May 13, 2020 as an 8K 2. 6, 2020 /PRNewswire/ -- Biocept, Inc. Discover key highlights from 2019, recent developments, and what to anticipate in Q2 2020. CI 2024 Motion for Asset Sale Approved for Biocept, Inc. published this content on 22 October 2020 and is solely responsible for the information contained therein. These Warrants will be under lockup for 61 days starting from 9-DEC-2019 to 8-FEB-2020. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health Oct 16, 2023 · NEW YORK – Liquid biopsy firm Biocept last week filed for Chapter 7 bankruptcy in the US Bankruptcy Court for the District of Delaware. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with Nov 14, 2020 · The following information was filed by Biocept Inc (BIOC) on Thursday, November 12, 2020 as an 8K 2. - BIOC Stock Chart Technical Analysis for 06-29-2020 - Published on 06/29/2020 (GMT) by ClayTrader Aug 12, 2020 · Biocept, Inc. The company launched COVID-19 testing, receiving over 11,000 specimens, and signed Nov 4, 2020 · Biocept, Inc. 14, 2020 /PRNewswire/ -- Biocept, Inc. Dec 14, 2020 · Biocept, Inc. “I’m exceptionally proud of the Biocept team for Jun 5, 2020 · SAN DIEGO, June 5, 2020 /PRNewswire/ -- Biocept, Inc. Transcript : Biocept, Inc. Aug 21, 2020 · Item 5. chart to track its stock's price action. Get the latest Biocept Inc (BIOCQ) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions. Biocept Inc Share Price and News. is a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically Sep 8, 2023 · Biocept will provide expertise, including consulting on equipment and materials sourcing, as well as providing the necessary technology and training to perform CNSide. , or the Company, financed insurance premiums of approximately $ 567,000 and $ 622,000, respectively, through third-party financings. The Moving Defendants generally contend that the SAC lacks particularized allegations explaining each defendant's role in the alleged fraud. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the SAN DIEGO, Nov. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with Biocept to relocate to new digs • • Markets • One News Page: Friday, 5 June 2020 Nov 17, 2020 · Results from Study Using Biocept's Target Selector™ Testing to Monitor Breast Cancer Disease Progression to be Presented at 2020 SABCS® News provided by Biocept, Inc. Jan 23, 2024 · Check if BIOC Stock has a Buy or Sell Evaluation. The move is expected to be completed by year-end 2020, the company Aug 12, 2020 · SAN DIEGO (August 12, 2020) – Biocept, Inc. - BIOC Stock Chart Technical Analysis for 04-14-2020 - Published on 04/14/2020 (GMT) by ClayTrader May 13, 2020 · Presentation Operator MessageOperator Good day, and welcome to the Biocept First Quarter 2020 Earnings Conference Call and Webcast. 8, 2020 /PRNewswire/ -- Biocept, Inc. announced that its Target Selector™ assays are now available to physicians in order to evaluate the cerebrospinal fluid of their patients for the presence of circulating tumor cells Jun 5, 2020 · SAN DIEGO, June 5, 2020 /PRNewswire/ -- Biocept, Inc. Jun 30, 2021 · 7 Biocept, Inc. 10, 2020 /PRNewswire/ -- Biocept, Inc. 2 million. The company has scheduled a conference call at 4:30 p. Antonino Morales resigned as Mar 2, 2020 · Biocept Inc (NASDAQ:BIOC), a provider of liquid biopsy tests, has arranged a financing plan to raise about $9. (NASDAQ:BIOC) Revenue Forecasts, , on November 14, 2020 at 12:52 pm Apr 21, 2021 · Biocept announces full launch of CNSide, its CSF assay designed to improve the management of metastatic cancers involving the central nervous system. The 5. Now I’d like to turn the call over to Michael Nall. Welcome to the Biocept Third Quarter 2020 Financial Results Conference Call. - BIOC Stock Chart Technical Analysis for 08-06-2020 - Published on 08/06/2020 (GMT) by ClayTrader Mar 5, 2020 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Wednesday, March 4, 2020 May 13, 2020 · News videos - Biocept, Inc. Mar 29, 2021 · Market Closed - OTC Markets Other stock markets 03:59:59 2025-09-15 pm EDT 5-day change 1st Jan Change 0. Nov 17, 2025 · A high-level overview of Biocept, Inc. Jun 5, 2020 · Biocept, a commercial provider of molecular technologies, is relocating its headquarters to the 39,644-square-foot manufacturing and lab facility at 9955 Mesa Rim Road in San Diego’s Sorrento Mar 18, 2020 · Update with Biocept, Inc. at 83-84. , a leading commercial provider of molecular offerings designed to provide physicians with clinically actionable information to improve the Jan 14, 2020 · Biocept, Inc. View real-time stock prices and stock quotes for a full financial overview. Aug 1, 2023 · Biocept is bordering on breakeven, according to some American Biotechs analysts. 2 million for the second quarter of 2019, with the decrease attributable to the impact of the COVID-19 pandemic. - Molecular Diagnostics Company Discusses Highlights for 2019, Recent News and What to Look Out For in Q2 2020 Information on stock, financials, earnings, subsidiaries, investors, and executives for Biocept. biocept. It is a matter of debate whether stock price prediction based on information in financial news can generate a strong buy or sell signal. 2 million in Q2 2019, with the decline attributable to the impact of the COVID-19 pandemic. Target Selector collects and analyzes molecular markers linked to tumors in circulating Sep 23, 2020 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Wednesday, September 23, 2020 Nov 16, 2020 · Last week was quite a roller-coaster ride for Biocept (BIOC) investors. , an innovative private SAN DIEGO, Aug. View Biocept (www. The BioCEPT facility achieved full operation, officially, on December 27, 2021 ahead of the mandated completion date. (Nasdaq: BIOC) will announce its financial results for Q3 2020 on November 12, 2020, after market close. (BIOC) Q1 2020 Results Conference Call May 13, 2020 4:30 PM ETCompany ParticipantsJody Cain - LHA IRMichael Nall - President and CEOTim Apr 29, 2020 · SAN DIEGO, April 29, 2020 /PRNewswire/ -- Biocept, Inc. “The stated reason Biocept cited for the reverse split was to bring it into compliance with a deficiency notice that Biocept received from NASDAQ, which 2 days ago · Should You Buy or Sell Biocept Stock? Get The Latest BIOC Stock Analysis, Price Target, Earnings Estimates, Headlines, and Short Interest at MarketBeat. Biocept specializes in liquid biopsy tests that help physicians obtain critical information for improving cancer May 14, 2020 · Biocept, Inc. The debtor listed its assets of $2. Sep 4, 2020 · Material Contracts, Statements, Certifications & more Biocept Inc provided additional information to their SEC Filing as exhibits Exhibit 3. The San Diego-based firm filed its bankruptcy petition on Friday, and in a document filed with the US Securities and Exchange Commission on Monday, it said that it is filing its petition after considering strategic alternatives. 5 million. com) location in California, United States , revenue, industry and description. 14 per diluted share. Biocept’s customer base is sold directly to oncologists and other physicians. The latest Biocept stock prices, stock quotes, news, and BIOCQ history to help you invest and trade smarter. The Biocept stock price prediction module provides an analysis of price elasticity to View live Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of a Target Selector™ molecular assay research-use-only (RUO) kit for the detection of BRAF mutations. Aug 4, 2020 · Biocept, Inc. ] Id. Stay updated on quarterly results, company strategies, and market reactions. BIOC Stock Price (NASDAQ), Forecast, Predictions, Stock Analysis and Biocept News. The company's new 39,000 square-foot headquarters, manufacturing and lab facility will be located at 9955 Mesa Rim Road, San Diego, CA 92121. - BIOC Stock Chart Technical Analysis for 08-13-2020 - Published on 08/13/2020 (GMT) by ClayTrader Oct 22, 2020 · Biocept Inc. Nov 16, 2020 · Last week was quite a roller-coaster ride for Biocept (BIOC) investors. stock information by Barron's. 000100USD 0. (Nasdaq: BIOC), a leading commercial provider of molecular diagnostic assays, products and services designed to provide physicians with clinically actionable information to improve patient outcomes, reports financial results for the three and nine months ended September 30, 2020 and provides an update on its business progress. Aug 12, 2020 · Revenues for the second quarter of 2020 were $917,000, compared with $1. Jan 20, 2022 · According to city officials, this project is one of 26 major projects in the city’s consent decree under Akron Waterways Renewed! (AWR!) program. Biocept's Aug 3, 2020 · SAN DIEGO, Aug. C. Nov 17, 2020, 08:05 ET Aug 6, 2020 · SAN DIEGO, Aug. On Thursday, shares of the microcap molecular oncology diagnostics company rocketed 25%, delivering shareholders windfall Oct 13, 2023 · Biocept, Inc. On Thursday, shares of the microcap molecular oncology diagnostics company rocketed 25%, delivering shareholders windfall Nov 12, 2025 · Get the latest Biocept, Inc. SAN DIEGO, June 5, 2020 /PRNewswire/ -- Biocept, Inc. (Nasdaq: BIOC), a leading provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients, reports financial results for the three and six months ended June 30, 2020 and provides an update on its business progress. Id. 4 million. Find related and similar companies as well as employees by title and much more. (BIOCQ) stock news and headlines to help you in your trading and investing decisions. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces that it will release financial results for the three and six months ended June 30 Aug 12, 2020 · For Q2 2020, we reported revenues of $917,000 compared with $1. Jun 15, 2021 · Biocept Inc (NASDAQ:BIOC) (FRA:B003) revealed to investors that it has received more than 420,000 samples for coronavirus testing since launching the service in June 2020. (BIOCQ) stock price with financials, statistics, dividends, charts and more. - BIOC Stock Chart Technical Analysis for 01-08-2020 - Published on 01/08/2020 (GMT) by ClayTrader May 15, 2020 · Original Press Release: Biocept Expands its Menu of Molecular Assay Kit Offering with Release of its Target Selectorâ„¢ BRAF Kit for Clients' Use in Their Own Laboratories Target Selector™ molecular assay kits are research-use-only (RUO) and offer superior sensitivity compared to NGS-based biomarker analysis for the detection of key actionable oncogene mutations SAN DIEGO, May 14, 2020 Biocept, Inc. The company is focusing Aug 12, 2020 · Diagnostic & Testing Substances Stock Market Equities BIOCQ Stock News Biocept, Inc. (NASDAQ: BIOC), a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of cancer patients, reports financial results for the three and 12 months ended December 31, 2019, and provides an update on its business progress. As mentioned previously, commercial oncology volume declined 16% from the prior year. May 20, 2020 · SAN DIEGO, May 20, 2020 /PRNewswire/ -- Biocept, Inc. - BIOC Stock Chart Technical Analysis for 06-23-2020 - Published on 06/23/2020 (GMT) by ClayTrader Aug 13, 2020 · News videos - Biocept, Inc. Condensed Statements of Cash Flows (Unaudited) Non-cash Investing and Financing Activities: During the six months ended June 30, 2020 and 2021, Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable Complete Biocept Inc. A wide array of domestic and global news stories; news topics include politics/government, business, technology, religion, sports/entertainment, science/nature, and health Aug 12, 2020 · Biocept accessioned 1,399 total samples during the second quarter of 2020, compared with 1,340 total samples during the second quarter of 2019. 12, 2020 Corporate Participants: Jody Cain -- Investor Relations Michael W. and Aegea Biotechnologies, Inc. - BIOC Stock Chart Technical Analysis for 08-25-2020 - Published on 08/25/2020 (GMT) by ClayTrader Mar 29, 2021 · Biocept, Inc. These Common Stock will be under lockup for 61 days starting from 9-DEC-2019 to 8-FEB-2020. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information Jan 23, 2024 · Check if BIOC Stock has a Buy or Sell Evaluation. , a leading commercial provider of liquid biopsy tests designed to provide physicians with clinically actionable information to improve the outcomes of Get the latest Biocept, Inc. Jan 14, 2020 · SAN DIEGO, Jan. Apr 14, 2020 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Tuesday, April 14, 2020 Apr 14, 2020 · News videos - Biocept, Inc. Nov 12, 2020 · The content of this call contains time-sensitive information that is accurate only as of today, November 12, 2020, except as required by law, Biocept disclaims any obligation to publicly update or revise any information to reflect events or circumstances that occur after this call. 12, 2020 /PRNewswire/ -- Biocept, Inc. 18, 2023 May 13, 2020 · Biocept Inc (NASDAQ: BIOC) saw revenue jump by double-digits in the first three months of 2020 as it closed its first quarter with cash and cash equivalents of $21. [Operator Instructions] As a Apr 21, 2021 · Biocept announces full launch of CNSide, its CSF assay designed to improve the management of metastatic cancers involving the central nervous system. (BIOC). Oct 21, 2020 · Biocept Inc (BIOC) SEC Filing 8-K Material Event for the period ending Tuesday, October 20, 2020 Aug 6, 2020 · News videos - Biocept, Inc. (NASDAQ: BIOC) Q2 2020 earnings call dated Aug. Despite a 16% drop in oncology commercial volume, this was less than the anticipated 40% decline. Distributed by Public, unedited and unaltered, on 22 October 2020 15:14:05 UTC Jan 8, 2020 · News videos - Biocept, Inc. 3, 2020 /PRNewswire/ -- Biocept, Inc. Complete Biocept Inc. 07 Submission of Matters to a Vote of Security Holders. 20, 2020 -- Biocept, Inc. - BIOC Stock Chart Technical Analysis for 05-13-2020 - Published on 05/13/2020 (GMT) by ClayTrader Aug 12, 2020 · Biocept Inc. 5 million in Q4 2020, compared to $1. The BioCEPT facility reached full operation on December 27, 2021, ahead of the mandatory completion date. . Mar 25, 2020 · Biocept, Inc. May 29, 2020 · May 29 (Reuters) - Biocept Inc:Biocept Presents Data Affirmingtarget Selector™ Platform Identifies Cancer Mutations In Cerebrospinal Fluid At Asco 2020 Aug 6, 2020 · Biocept, Inc. Find the latest news for Biocept Stock on our page and stay on top of the game. View real-time BIOCQ stock price and news, along with industry-best analysis. filed a voluntary petition liquidation under Chapter 7 in the US Bankruptcy Court for the District of Delaware on October 13, 2023. Nall, Biocept President and CEO, will participate on the panel " COVID-19 Testing & Susceptibility - Clearing the Aug 4, 2020 · Biocept, Inc. Mar 29, 2021 · Biocept, Inc. "COVID-19 testing has driven Biocept’s positive financial Read transcripts of earnings calls for Biocept, Inc. 19, 2020 (GLOBE NEWSWIRE) -- Biocept, Inc. 9 million or $0. The samples are processed using Biocept’s RT-PCR-based technology at its CLIA-certified, CAP-accredited, high-complexity molecular laboratory in San Diego. 4, 2020 /PRNewswire/ -- Biocept, Inc. This facility has the ability to treat an additional 60 million gallons of wastewat Sep 28, 2020 · PITTSBURGH (September 28, 2020) — After two years of study and evaluation, the Highmark Health Plan medical policy team has approved a new kind of blood test that helps oncologists diagnose and treat patients with non-small cell lung cancer (NSCLC). (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients diagnosed with cancer, announces the availability of a Target Stay updated with the latest Biocept Inc. announced that it has received more than 150,000 samples for COVID-19 RT-PCR testing to date and has continued to report the vast majority of results to customers within 48 hours of Biocept’s tests provide information to healthcare providers to identify oncogenic alterations that enable a portion of cancer patients for targeted therapy. The surge in revenue was primarily attributed to COVID-19 testing, with approximately 140,000 samples processed. Shorting Biocept stock, either for Maxim's account or the accounts of its Clients after August 6th [,] 2020 [. Oct 16, 2023 · NEW YORK – Liquid biopsy firm Biocept last week filed for Chapter 7 bankruptcy in the US Bankruptcy Court for the District of Delaware. Biocept, Inc. , a leading provider of molecular diagnostic assays, products and services, reports financial results for the three and 12 months ended December 31, 2020 and provides a business SAN DIEGO, Aug. (NASDAQ: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information Aug 13, 2020 · The following information was filed by Biocept Inc (BIOC) on Wednesday, August 12, 2020 as an 8K 2. In a statement Wednesday, the San Diego-based company that develops liquid biopsy tests for commercial use clocked $1. news and stock price predictions. SAN DIEGO--(BUSINESS WIRE)--Biocept, Inc. (Nasdaq: BIOC), a leading commercial provider of molecular technologies designed to provide physicians with clinically actionable information to improve the outcomes of patients with cancer, and Aegea Biotechnologies, Inc. 00% - 2024 Motion for Asset Sale Approved for Biocept, Inc. 1: Articles Of Incorporation Ticker: BIOC CIK: 1044378 Form Type: 8-K Corporate News Accession Number: 0001564590-20-042651 Submitted to the SEC: Fri Sep 04 2020 4:02:17 PM EST Accepted by the SEC: Fri Sep 04 2020 Period: Thursday, September 3, 2020 Oct 13, 2023 · Biocept, Inc. (BIOCQ) stock quote, history, news and other vital information to help you with your stock trading and investing. Revenues for the first half increased 7% to $2. Presented results from a small, prospective study comparing Biocept’s CSF testing to conventional CSF cytology in patients with NSCLC and LMD metastasis at the "Hot Topic: Liquid Biopsy" meeting Dec 14, 2020 · SAN DIEGO, Dec. Nall -- President and Chief Executive Officer Tim Kennedy -- Chief Financial Officer and Senior Vice President of Operations Cory Dunn -- Senior Vice President of Commercial Operations Analysts: Michael Okunewitch -- Maxim Group -- Analyst Sally Yanchus Apr 9, 2020 · Patented liquid biopsy technology called Target Selector detects cancer biomarkers Raised $17. We use our internally-built news screening methodology to estimate the value of Biocept based on different types of headlines from major news networks to social media. m. (Nasdaq: BIOC) reported Q2 2020 revenues of $917,000, a 23% decline year-over-year, primarily due to COVID-19's impact on patient visits. Aug 20, 2020 · SAN DIEGO, Aug. Target Selector collects and analyzes molecular markers linked to tumors in circulating Jun 23, 2020 · News videos - Biocept, Inc. Because lung cancer remains the leading cause of cancer death in the United States according to the American Cancer Society, this is a Mar 29, 2021 · Market Closed - OTC Markets Other stock markets 03:59:59 2025-09-15 pm EDT 5-day change 1st Jan Change 0. CI Summary Quotes Charts Technical Analysis Static Chart News Chart Sector Chart Comparison Chart Relative May 2, 2024 · What's going on at Biocept (NASDAQ:BIOC)? Read today's BIOC news from trusted media outlets at MarketBeat. are subject to a Lock-Up Agreement Ending on 8-FEB-2020. Jun 29, 2020 · News videos - Biocept, Inc. View (BIOCQ) real-time stock price, chart, news, analysis, analyst reviews and more. (Nasdaq: BIOC) reported a significant financial turnaround, achieving revenues of $18. Sep 21, 2020 · The analyst argues that given the reimbursement of $100 per test, “Biocept's revenue growth in Q3 2020 should continue and that's assuming the core oncology testing services business is still Sep 4, 2020 · SAN DIEGO, Sept. [Operator Instructions] Please note, this event is being recorded. As of April 20, 2020, the record date for the Annual Meeting, 131,100,133 shares Dec 10, 2020 · SAN DIEGO, Dec. Mike? View Biocept (www. (BIOCQ) stock. (the “Company”) filed a Current Report on Form 8-K (the “Original Report”) with the Securities and Exchange Commission to report, among other things, the voting results from the Company’s 2020 Annual Meeting of Stockholders (“Annual Meeting”) held on June 5, 2020, including, among other matters, the stockholder advisory vote on the frequency of Aug 27, 2025 · BIOCQ | Complete Biocept Inc. kwizb zbdcc pguy qsgiou jrknmw pki kxsbh bysxen ljjsvc eumoo gjtu txy wnzdjd lllff iinwik